146 related articles for article (PubMed ID: 38503998)
1. Investigation of imaging features in contrast-enhanced magnetic resonance imaging of benign and malignant breast lesions.
Kubota K; Fujioka T; Tateishi U; Mori M; Yashima Y; Yamaga E; Katsuta L; Yamaguchi K; Tozaki M; Sasaki M; Uematsu T; Monzawa S; Isomoto I; Suzuki M; Satake H; Nakahara H; Goto M; Kikuchi M
Jpn J Radiol; 2024 Mar; ():. PubMed ID: 38503998
[TBL] [Abstract][Full Text] [Related]
2. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
3. Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast.
Tozaki M; Yabuuchi H; Goto M; Sasaki M; Kubota K; Nakahara H
Breast Cancer; 2021 Jul; 28(4):927-936. PubMed ID: 33625722
[TBL] [Abstract][Full Text] [Related]
4. Computer-Aided Diagnosis in Multiparametric Magnetic Resonance Imaging Screening of Women With Extremely Dense Breasts to Reduce False-Positive Diagnoses.
Verburg E; van Gils CH; Bakker MF; Viergever MA; Pijnappel RM; Veldhuis WB; Gilhuijs KGA
Invest Radiol; 2020 Jul; 55(7):438-444. PubMed ID: 32149858
[TBL] [Abstract][Full Text] [Related]
5. The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.
Kawai M; Kataoka M; Kanao S; Iima M; Onishi N; Ohashi A; Sakaguchi R; Toi M; Togashi K
Magn Reson Med Sci; 2018 Jul; 17(3):203-210. PubMed ID: 29213007
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation of Kaiser score in diagnosing breast dynamic contrast-enhanced magnetic resonance imaging for patients with high-grade background parenchymal enhancement.
Wang H; Gao L; Chen X; Wang SJ
Quant Imaging Med Surg; 2023 Oct; 13(10):6384-6394. PubMed ID: 37869283
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps.
Schmitz AC; Peters NH; Veldhuis WB; Gallardo AM; van Diest PJ; Stapper G; van Hillegersberg R; Mali WP; van den Bosch MA
Eur Radiol; 2008 Feb; 18(2):355-64. PubMed ID: 17882425
[TBL] [Abstract][Full Text] [Related]
8. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
[TBL] [Abstract][Full Text] [Related]
9. Motion artifacts, lesion type, and parenchymal enhancement in breast MRI: what does really influence diagnostic accuracy?
Clauser P; Dietzel M; Weber M; Kaiser CG; Baltzer PA
Acta Radiol; 2019 Jan; 60(1):19-27. PubMed ID: 29667880
[TBL] [Abstract][Full Text] [Related]
10. A pilot study to determine the diagnostic criteria of spiculated masses for BI-RADS MRI category 5: when to perform re-biopsy after discordant pathologic result?
Onishi N; Kataoka M; Kanao S; Kawai M; Iima M; Ohashi A; Toi M; Togashi K
Breast Cancer; 2017 Jan; 24(1):69-78. PubMed ID: 26832858
[TBL] [Abstract][Full Text] [Related]
11. A simplified scoring protocol to improve diagnostic accuracy with the breast imaging reporting and data system in breast magnetic resonance imaging.
Zhong Y; Li M; Zhu J; Zhang B; Liu M; Wang Z; Wang J; Zheng Y; Cheng L; Li X
Quant Imaging Med Surg; 2022 Jul; 12(7):3860-3872. PubMed ID: 35782247
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the applicability of BI-RADS® MRI for the interpretation of contrast-enhanced digital mammography.
Travieso-Aja MM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Luzardo OP
Radiologia (Engl Ed); 2019; 61(6):477-488. PubMed ID: 31262509
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
[TBL] [Abstract][Full Text] [Related]
14. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
[TBL] [Abstract][Full Text] [Related]
15. False-positive incidental lesions detected on contrast-enhanced breast MRI: clinical and imaging features.
Alikhassi A; Li X; Au F; Kulkarni S; Ghai S; Allison G; Freitas V
Breast Cancer Res Treat; 2023 Apr; 198(2):321-334. PubMed ID: 36740611
[TBL] [Abstract][Full Text] [Related]
16. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
Milos RI; Pipan F; Kalovidouri A; Clauser P; Kapetas P; Bernathova M; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Nov; 30(11):6052-6061. PubMed ID: 32504098
[TBL] [Abstract][Full Text] [Related]
17. Breast non-mass-like lesions on contrast-enhanced ultrasonography: Feature analysis, breast image reporting and data system classification assessment.
Xu P; Yang M; Liu Y; Li YP; Zhang H; Shao GR
World J Clin Cases; 2020 Feb; 8(4):700-712. PubMed ID: 32149054
[TBL] [Abstract][Full Text] [Related]
18. Value of multimodal imaging in the diagnosis of breast sclerosing adenosis associated with malignant lesions.
Chen H; Bao L; Yu L; Sun H; Tan Y; Wei P; Zheng Z
J Clin Ultrasound; 2023 Mar; 51(3):485-493. PubMed ID: 36250329
[TBL] [Abstract][Full Text] [Related]
19. Characteristics, Malignancy Rate, and Follow-up of BI-RADS Category 3 Lesions Identified at Breast MR Imaging: Implications for MR Image Interpretation and Management.
Chikarmane SA; Birdwell RL; Poole PS; Sippo DA; Giess CS
Radiology; 2016 Sep; 280(3):707-15. PubMed ID: 27089027
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging features for differentiating breast papilloma with high-risk or malignant lesions from benign papilloma: a retrospective study on 158 patients.
Wang LJ; Wu P; Li XX; Luo R; Wang DB; Guan WB
World J Surg Oncol; 2018 Dec; 16(1):234. PubMed ID: 30558621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
